D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia

NCT00237848 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: D-serine
BEHAVIORAL: Cognitive retraining

Sponsor

Yale University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]